Determinants of survival in patients with chronic myeloid leukaemia treated in the new era of oral therapy: findings from a UK population-based patient cohort.
about
The role of observational studies in optimizing the clinical management of chronic myeloid leukemiaEstimating the prevalence of hematological malignancies and precursor conditions using data from Haematological Malignancy Research Network (HMRN).Emergency admission and survival from aggressive non-Hodgkin lymphoma: A report from the UK's population-based Haematological Malignancy Research NetworkLow educational level but not low income impairs the achievement of cytogenetic remission in chronic myeloid leukemia patients treated with imatinib in Brazil.Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK's Haematological Malignancy Research Network.Chronic myeloid leukemia incidence, survival and accessibility of tyrosine kinase inhibitors: a report from population-based Lithuanian haematological disease registry 2000-2013A Multi-centric Bioequivalence Trial in Ph+ Chronic Myeloid Leukemia Patients to Assess Bioequivalence and Safety Evaluation of Generic Imatinib Mesylate 400 mg TabletsEpidemiology of MPN: what do we know?Immunology of chronic myeloid leukemia: current concepts and future goals.Epidemiology of chronic myeloid leukaemia: an update.Update on emerging treatments for chronic myeloid leukemia.The impact of socio-economic factors on treatment choice and mortality in chronic myeloid leukaemia.Improved survival boosts the prevalence of chronic myeloid leukemia: predictions from a population-based study.Population-based assessment of chronic myeloid leukemia in Sweden: striking increase in survival and prevalence.Treatment and outcome of 2904 CML patients from the EUTOS population-based registry.Impact of age and socioeconomic status on treatment and survival from aggressive lymphoma: a UK population-based study of diffuse large B-cell lymphoma.Myeloid malignancies in the real-world: Occurrence, progression and survival in the UK's population-based Haematological Malignancy Research Network 2004-15.Cohort Profile: The Haematological Malignancy Research Network (HMRN); a UK population-based patient cohort.The impact of introducing tyrosine kinase inhibitors on chronic myeloid leukemia survival: a population-based study
P2860
Q28085149-B2C3D1D9-CA3B-4E96-BC7D-4E32D0F3D813Q31111112-D567C17C-5995-4FA0-BEAC-5DF43546A6C2Q33732402-3FCE6CD4-EB4C-4B98-9403-060FCFD9D129Q35666534-6277FF67-AF60-4EA2-8DB5-88404B43EBB1Q35677959-4AE3307E-9A52-464B-A7EE-666ED402073FQ35949910-EAFB9CB5-E042-4796-8864-D9426B601C0AQ37097538-35A531F8-70F1-4E8D-BCA9-F615718E47B2Q38240406-B4B48A6B-4F1F-4EF2-A941-154C9EBF9C07Q38366539-DC9E50E5-5B70-426C-A732-A4ED48EC253CQ38392709-FDE2F4E4-49DC-41DF-ADC7-242E910AAC68Q38397515-ABB27623-BA6B-4AC1-B416-C0A80A49E035Q38403647-C30E8190-DB35-4B96-99A5-DFF2B7268C14Q38880265-DF915F9A-A299-4C8D-B71B-2CD70F6A43D5Q38913462-5B9D234B-68FE-4E48-94BC-36533780A055Q39446340-CDAA5005-523E-4725-A618-39C866EB3A96Q50794996-02B206A4-D8BD-4B52-8617-62E1D168B8A0Q50976585-FA345536-12E4-442A-AC0E-8AC52EA4AEC8Q52802234-D4247A27-42F0-4220-8DFE-5487F7479E40Q58605235-0965FD87-FAD2-48CC-9495-A9A51808DEDD
P2860
Determinants of survival in patients with chronic myeloid leukaemia treated in the new era of oral therapy: findings from a UK population-based patient cohort.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Determinants of survival in pa ...... pulation-based patient cohort.
@en
Determinants of survival in pa ...... pulation-based patient cohort.
@nl
type
label
Determinants of survival in pa ...... pulation-based patient cohort.
@en
Determinants of survival in pa ...... pulation-based patient cohort.
@nl
prefLabel
Determinants of survival in pa ...... pulation-based patient cohort.
@en
Determinants of survival in pa ...... pulation-based patient cohort.
@nl
P2093
P2860
P1433
P1476
Determinants of survival in pa ...... pulation-based patient cohort.
@en
P2093
P2860
P304
P356
10.1136/BMJOPEN-2013-004266
P50
P577
2014-01-15T00:00:00Z